Balancear el riesgo de sangrado vs trombótico para definir el tiempo de doble antiagregación

Clopidogrel Monotherapy Beyond 12 months: Long Term Analysis of the STOPDAPT-2

Short dual antiplatelet therapy (DAPT) has shown benefits in patients receiving drug eluting stents (DES), reducing bleeding with no concomitant increase in major adverse cardiovascular events (MACE). Traditionally, the therapeutic window was limited to monotherapy with P2Y12 inhibitors during the first year and there are few data on short DAPT followed by long term monotherapy<a href="https://solaci.org/en/2024/01/29/clopidogrel-monotherapy-beyond-12-months-long-term-analysis-of-the-stopdapt-2/" title="Read more" >...</a>

Nuevo dispositivo para tener mayor protección en la angioplastia carotídea

Carotid Stenosis and TAVR

Aortic Stenosis affects over 5% of the population over 65.  Even though TAVR has advanced in the treatment of this disease, many patients present carotid aortic stenosis (CAS), which involves additional surgical risk. This risk has not been thoroughly assessed in the context of TAVR.  A meta-analysis was carried out including 5 observational studies with<a href="https://solaci.org/en/2024/01/12/carotid-stenosis-and-tavr/" title="Read more" >...</a>

See the Presentations of the 2023 Perú Sessions

The XLVII SOLACI Regional Sessions – 16th Andean Region took place in Lima, Peru, between November 16 and 17, 2023.It was an extremely successful event that featured the participation of prestigious national and international guests and a high-level scientific program. Below, we share some of the presentations that were made during the Sessions. Dra. Carla<a href="https://solaci.org/en/2023/12/20/see-the-presentations-of-the-2023-peru-sessions/" title="Read more" >...</a>

Complex Coronary Angioplasty in Elderly Patients: Problem or Solution?

Cardiovascular disease is the leading cause of death in elderly adults (individuals aged 75 years or older). In turn, coronary heart disease is one of the main causes of morbidity in this population. In addition to anatomical complexities, there are other factors that may complicate its management, such as polypharmacy, frailty, and procedure-related risks. All of<a href="https://solaci.org/en/2023/10/18/complex-coronary-angioplasty-in-elderly-patients-problem-or-solution/" title="Read more" >...</a>

Diabetes y enfermedad vascular periférica: viejas drogas con nueva evidencia

BIFURCAT Registry: Long Term Diabetes Impact on Bifurcations PCI Outcomes

The impact of diabetes in patients with coronary artery disease (CAD) are well known, and after percutaneous coronary intervention (PCI), outcomes tend to be less favorable, with higher restenosis rate, repeat myocardial infarction (MI) and stent thrombosis. Despite the development of drug eluting stents, procedures and techniques, treating bifurcation lesions in diabetic patients still show<a href="https://solaci.org/en/2023/09/15/bifurcat-registry-long-term-diabetes-impact-on-bifurcations-pci-outcomes/" title="Read more" >...</a>

ESC 2023 | Extended Monotherapy with Clopidogrel vs. DAPT in High-Risk Patients

An increasing number of patients currently present both an elevated ischemic risk and hemorrhagic risk. This means that the selection of the optimal antiplatelet treatment is a clinical challenge. Several studies have shown that P2Y12 monotherapy after minimum dual antiplatelet therapy (DAPT) is a novel strategy to reduce bleeding risk without increasing ischemic risk. Furthermore,<a href="https://solaci.org/en/2023/08/30/esc-2023-extended-monotherapy-with-clopidogrel-vs-dapt-in-high-risk-patients/" title="Read more" >...</a>

ESC 2023 | STOPDAPT-3

Short Dual antiplatelet therapy (DAPT), one to three months, followed by P2Y12 inhibitor monotherapy has been shown to reduce bleeding events without increased cardiovascular events vs. standard DAPT, according to guidelines.  However, the rate of major bleeding within the first month after procedure remains significant when using these strategies.  The use of aspirin-free therapies (ASA)<a href="https://solaci.org/en/2023/08/29/esc-2023-stopdapt-3-2/" title="Read more" >...</a>

La insuficiencia renal post tratamiento borde a borde tricuspídeo impacta en el pronóstico

bRight: Impact and Safety of the TriClip Device in a Real-World Cohort

The clinical importance of severe tricuspid regurgitation (TR) has been underestimated for many years now. However, studies and registries have shown that, when left untreated, this pathology significantly increases morbidity and mortality. Patients in need of treatment are often older individuals with higher surgical risk due to the prevalence of this condition. Contemporary data has<a href="https://solaci.org/en/2023/08/14/bright-impact-and-safety-of-the-triclip-device-in-a-real-world-cohort/" title="Read more" >...</a>

El ticagrelor muestra beneficios en la función microvascular coronaria luego de un IAMSEST

Secondary Prevention with P2Y12 Inhibitors: How Consolidated Is This Long Term Alternative vs. Aspirin?

Secondary prevention with P2Y12 inhibitors vs aspirin monotherapy in CAD patients Antiaggregation therapy plays a central role at long term to prevent new cardiovascular events in atherosclerosis patients.  After repeat myocardial infarction (MI) or stroke, prognosis can vary considerably. Even though the current guidelines prefer aspirin as the first choice for secondary prevention over P2Y12<a href="https://solaci.org/en/2023/07/13/secondary-prevention-with-p2y12-inhibitors-how-consolidated-is-this-long-term-alternative-vs-aspirin/" title="Read more" >...</a>

Simplified Rapid Intravenous Hydration for the Prevention of Contrast-Induced Nephropathy in Patients with Chronic Kidney Disease

Patients with chronic kidney disease (CKD) undergoing coronary angiography are at increased risk of developing contrast-associated acute kidney injury (CA-AKI), which is associated with increased mortality. According to current guidelines, the standard treatment for preventing CA-AKI in patients with moderate to severe CKD is long-duration peri-procedural intravenous hydration with saline solution. This standard hydration is<a href="https://solaci.org/en/2023/07/13/simplified-rapid-intravenous-hydration-for-the-prevention-of-contrast-induced-nephropathy-in-patients-with-chronic-kidney-disease/" title="Read more" >...</a>

acute myocardial infarction